J. Larsson et A. Hillarp, The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism Pl(A2) in patients with central retinal vein occlusion, THROMB RES, 96(4), 1999, pp. 323-327
The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa po
lymorphism pl(A2) have been shown to be associated with thromboembolic dise
ase. We wondered if mutations were overrepresented in patients with central
retinal vein occlusion. We studied 129 consecutive patients with a history
of central retinal vein occlusion. We analysed for the prothrombin gene G2
0210A mutation and the platelet glycoprotein IIIa polymorphism pl(A2) and c
ompared the results to controls with no history of thrombosis. For the plat
elet glycoprotein IIIa polymorphism Pl(A2), 69% were normal, 26% were heter
ozygous, and 5% were homozygous. For the G20210A prothrombin mutation, 97%
were normal and 3% were heterozygous. Neither the prothrombin gene G20210A
mutation nor the platelet glycoprotein IIIa polymorphism pl(A2) seem to be
associated with central retinal vein occlusion. (C) 1999 Elsevier Science L
td. All rights reserved.